Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$24.77K$24.77Kderived−24.4% vs Q4 2017 Net Income$2.52M$2.52MderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived-$31,923N/M Operating Incomederived-$351,306N/M Operating Cash Flowderived-$136,047N/M Margins · derivedGross margin-128.9%−217.3 pt vs Q4 2017
Operating margin-1418.1%−579.2 pt vs Q4 2017
Net margin10178.7%+13205.4 pt vs Q4 2017
ended Dec 31, 2018 · filed Feb 5, 2021 · 767 d after period end